ASH Bridge Grant Program Funds Eight Promising Biomedical Research Projects
Published on: October 11, 2018
October 11, 2018) — Today, ASH announced the names of eight investigators who have each been awarded
$150,000 through the ASH Bridge Grant Program. Designed to
support promising hematology research, ASH Bridge Grants will ensure that
innovative research continues at institutions across the country.
Institutes of Health (NIH) is the world’s top provider of medical research
grants. Though congressional leaders recognize the importance of funding NIH,
the regular threat of continuing resolutions and government shutdowns in recent
years has led to an unpredictable, unstable environment in which appropriations
are delayed and investigators are unsure of when their grants might be funded.
Without reliable funding, some spend valuable research time attempting to
identify alternative funding sources, and others stop their important studies
promising research amid the uncertainty, the ASH Bridge Grants are designed to
serve as a one-year bridge for researchers facing such gaps in multi-year
funding, giving them financial support to continue their studies and strengthen
their grant applications without the need to pare down laboratory staff or to
pause or end their work.
Since April 2013,
ASH has awarded over $15 million in Bridge Grant support to 115 investigators.
More than 70 percent of these recipients have gone on to receive R01 funding
from NIH within three years.
the federal research budget continue to impact investigators who are submitting
proposals for research studies that are deemed meritorious yet are not
funded.,” said ASH President Alexis A. Thompson, MD, MPH, of the Ann and Robert
H. Lurie Children’s Hospital of Chicago. “The ASH Bridge Grants are critical to
advancing this important research while maintaining America’s biomedical
workforce and our competitive edge in biopharmaceutical technology.”
host of basic, translational, and clinical hematology research, projects funded
in this 11th round of the ASH Bridge Grant Program include work that will
increase the safety of bone marrow transplants and advance our understanding of
why some leukemia patients relapse after treatment.
about the ASH Bridge Grants, as well as a list of every recipient of the award,
can be found on the ASH website.
American Society of Hematology (ASH) (www.hematology.org)
is the world’s largest professional society of hematologists dedicated to
furthering the understanding, diagnosis, treatment, and prevention of disorders
affecting the blood. For more than 50 years, the Society has led the
development of hematology as a discipline by promoting research, patient care,
education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org),
the most cited peer-reviewed publication in the field, which is available
weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org),
an online, peer-reviewed open-access journal.
back to top
Stephen Fitzmaurice, American Society of Hematology